Apollomics Inc. Launches "At the Market" Sales Program
Ticker: APLMW · Form: 6-K · Filed: May 24, 2024 · CIK: 1944885
| Field | Detail |
|---|---|
| Company | Apollomics Inc. (APLMW) |
| Form Type | 6-K |
| Filed Date | May 24, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $19 m, $19,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: at-the-market, equity-offering, financing
Related Tickers: APLM
TL;DR
APLM is selling shares via ATM program with Cantor Fitzgerald.
AI Summary
On May 24, 2024, Apollomics Inc. entered into a Sales Agreement with Cantor Fitzgerald & Co. as sales agent to establish an "At the Market" sales program. This program allows the company to offer and sell its Class A ordinary shares from time to time.
Why It Matters
This allows Apollomics to raise capital opportunistically by selling shares on the open market, potentially funding ongoing operations or future development.
Risk Assessment
Risk Level: medium — At-the-market programs can dilute existing shareholders and indicate potential cash flow needs.
Key Players & Entities
- Apollomics Inc. (company) — Registrant
- May 24, 2024 (date) — Date of Sales Agreement
- Cantor Fitzgerald & Co. (company) — Sales Agent
- Class A ordinary shares (security) — Shares to be sold
FAQ
What is the purpose of the Sales Agreement entered into by Apollomics Inc.?
The Sales Agreement establishes an "At the Market" sales program, allowing Apollomics Inc. to offer and sell its Class A ordinary shares from time to time.
Who is acting as the sales agent for Apollomics Inc. in this program?
Cantor Fitzgerald & Co. is acting as the sales agent for Apollomics Inc.
On what date was the Sales Agreement entered into?
The Sales Agreement was entered into on May 24, 2024.
What type of shares will be offered and sold under the "At the Market" program?
The company's Class A ordinary shares will be offered and sold under the program.
What is the filing type and its purpose?
This is a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, filed for the month of May 2024.
Filing Stats: 794 words · 3 min read · ~3 pages · Grade level 12.1 · Accepted 2024-05-24 17:03:50
Key Financial Figures
- $19 m — ng an aggregate offering price of up to $19 million, through or to the Sales Agent.
- $19,000,000 — ate upon the earlier of (1) the sale of $19,000,000 of the Companys Class A Ordinary Shares
Filing Documents
- d717064d6k.htm (6-K) — 15KB
- d717064dex11.htm (EX-1.1) — 209KB
- d717064dex51.htm (EX-5.1) — 28KB
- g717064dsp1.jpg (GRAPHIC) — 7KB
- 0001193125-24-147162.txt ( ) — 262KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. APOLLOMICS INC. Date: May 24, 2024 By: /s/ Guo-Liang Yu Name: Guo-Liang Yu Title: Chief Executive Officer